Codexis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Codexis, Inc. on September 3, 2013, covering the event date of September 2, 2013. The filing addresses a material modification to the rights of security holders regarding the expiration of a poison pill defense mechanism.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly legal in nature and does not contain financial performance data.
Material Changes
The primary material change reported is the expiration of the Rights Agreement dated September 3, 2012, between Codexis, Inc. and Wells Fargo Bank, N.A. As of 5:00 p.m. New York time on September 2, 2013:
- The preferred stock purchase rights distributed to common stockholders expired in accordance with the agreement terms.
- Shares of the Company's common stock are no longer accompanied by these Rights.
- The Rights Agreement is of no further force or effect.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The document notes that the terms of the expired Rights Agreement were previously described in a Form 8-K filed on September 4, 2012, and incorporates the full text of that agreement by reference. No new risks or contingencies are disclosed in this specific report.
Key Facts for Investor Verification
- Confirm that the anti-takeover Rights Agreement has officially expired as of September 2, 2013.
- Verify that common stock is now trading without the attached preferred stock purchase rights.
- Review the Prior 8-K filed on September 4, 2012, for the original terms of the expired Rights Agreement.